Medtronic Plc Income Statement Quarterly
MDT
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jan 26 2024) III. Quarter |
(Oct 27 2023) II. Quarter |
(Jul 28 2023) I. Quarter |
(Apr 28 2023) IV. Quarter |
(Jan 27 2023) III. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
8,089.00 |
7,984.00 |
7,702.00 |
|
7,727.00 |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
- |
|
- |
Total Revenue |
8,089.00 |
7,984.00 |
7,702.00 |
8,544.00 |
7,727.00 |
Cost of Goods and Services Sold |
2,782.00 |
2,761.00 |
2,628.00 |
2,979.00 |
2,689.00 |
Gross
Profit |
5,307.00 |
5,223.00 |
5,074.00 |
5,565.00 |
5,038.00 |
Selling, Administration, Marketing |
2,673.00 |
2,686.00 |
2,613.00 |
2,616.00 |
2,615.00 |
Depriciation & Amortization |
419.00 |
425.00 |
429.00 |
423.00 |
431.00 |
Research and Development Expense (Excluding Acquired in Process Cost) |
695.00 |
698.00 |
668.00 |
640.00 |
688.00 |
Restructuring |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
17.00 |
-31.00 |
2.00 |
390.00 |
-126.00 |
Unusual Income/ -Expense |
- |
- |
- |
- |
- |
Loss Contingency Accrual Provision |
- |
65.00 |
40.00 |
- |
- |
Restructuring Charges Net Of Restructuring Reversals Including Cost Of Product Sold Impact |
20.00 |
40.00 |
54.00 |
-68.00 |
38.00 |
Total operating costs including COS |
6,606.00 |
6,644.00 |
6,434.00 |
6,980.00 |
6,335.00 |
Operating income/-loss
|
1,483.00 |
1,340.00 |
1,268.00 |
1,564.00 |
1,392.00 |
Other Deductions / - Income |
Interest expense |
188.00 |
180.00 |
148.00 |
187.00 |
167.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
188.00 |
180.00 |
148.00 |
187.00 |
167.00 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Sale of Business |
- |
- |
- |
- |
- |
Sale of Assets |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
-177.00 |
-153.00 |
-76.00 |
-173.00 |
-150.00 |
Total costs & expenses |
6,617.00 |
6,671.00 |
6,506.00 |
6,994.00 |
6,352.00 |
Income /-loss before income taxes |
1,472.00 |
1,313.00 |
1,196.00 |
1,550.00 |
1,375.00 |
Income taxes expenses/-benefit |
135.00 |
402.00 |
400.00 |
363.00 |
146.00 |
Income after income taxes |
1,337.00 |
911.00 |
797.00 |
1,189.00 |
1,229.00 |
Net income/-loss
of other equity |
- |
- |
1.00 |
2.00 |
- |
Income/-loss
from cont. Ops. |
1,337.00 |
911.00 |
797.00 |
1,189.00 |
1,229.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
1,337.00 |
911.00 |
797.00 |
1,189.00 |
1,229.00 |
Noncontrolling interests |
-15.00 |
-2.00 |
-6.00 |
-10.00 |
-6.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
1,322.00 |
909.00 |
791.00 |
1,180.00 |
1,222.00 |
EBIT |
1,660.00 |
1,493.00 |
1,344.00 |
1,737.00 |
1,542.00 |
EBITD |
2,309.00 |
2,165.00 |
2,016.00 |
2,416.00 |
2,221.00 |
EBITDA |
2,309.00 |
2,165.00 |
2,016.00 |
2,416.00 |
2,221.00 |
Per
Share (GAAP Quarterly, in $) |
(Jan 26 2024) III. Quarter |
(Oct 27 2023) II. Quarter |
(Jul 28 2023) I. Quarter |
(Apr 28 2023) IV. Quarter |
(Jan 27 2023) III. Quarter |
Basic EPS (excl. extra
items) |
0.99 |
0.68 |
0.59 |
0.89 |
0.92 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
0.99 |
0.68 |
0.59 |
0.89 |
0.92 |
Basic shares outstanding (Mill.
of Units) |
1,329.70 |
1,330.20 |
1,330.50 |
1,330.20 |
1,330.20 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
0.99 |
0.68 |
0.59 |
0.89 |
0.92 |
Diluted average shares (Mill.
of Units) |
1,331.70 |
1,331.90 |
1,333.80 |
1,332.62 |
1,332.00 |
Dividend per share |
0.689 |
0.689 |
0.688 |
0.679 |
0.679 |
|
|